日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

您現在的位置: > Language Tips > Audio & Video > Special Speed News  
 





 
A one-pill answer to treating H.I.V.
[ 2006-07-27 09:43 ]

This is the VOA Special English Health Report.

The first treatment for H.I.V. in the form of one pill taken once a day is going to market in the United States. A spokesman for the drug company Bristol-Myers Squibb says the new product, called Atripla, has already been shipped to suppliers.

Atripla is the result of some unusual cooperation among drug companies. The government approved the treatment on July twelfth. Food and Drug Administration officials had until October to make a decision. But they acted quickly.

Doctors believe a one-pill-a-day plan will be more successful than current treatments which can involve several pills a day. Patients are less likely to miss treatments. Missed treatments can help the virus gain resistance to drugs.

Atripla combines three medicines widely used to treat the most common form of H.I.V., the virus that causes AIDS. One of the three is Sustiva, made by Bristol-Myers. The other two are Viread and Emtriva, both from Gilead Sciences.

The new tablets are approved for use alone or with other antiretroviral products to treat adults.

Earlier this year, the New England Journal of Medicine published a study of Atripla. Gilead paid for the study. Researchers compared the effectiveness of Atripla to the widely used combination of Sustiva and Combivir, from GlaxoSmithKline.

They reported that Atripla suppressed virus levels in more patients and with fewer side effects. A one-month supply in the United States will cost more than one thousand dollars, the same price as for the separate drugs it contains.

Gilead and Bristol-Myers will jointly market Atripla. AIDS activists praised the cooperation between drug makers as historic. They also called on them to provide the treatment to developing nations.

The Bristol-Myers spokesman says his company and Gilead want to do that. They are currently negotiating with Merck. That company has rights to market the active substance in Sustiva in a number of countries outside the United States.

The spokesman says the new product could be offered as early as September through the President's Emergency Plan for AIDS Relief. The plan provides drugs to fifteen poor countries, mostly in Africa. The Food and Drug Administration recently approved a two-pill-a-day H.I.V. treatment for use under the emergency plan.

And that's the VOA Special English Health Report, written by Caty Weaver. Transcripts and archives of our reports are at voaspecialenglish.com. I'm Barbara Klein.  

(來源:VOA   英語點津姍姍編輯)

 
 

 

 

 
 

48小時內最熱門

     

本頻道最新推薦

     
  Rains help ease crop worries in U.S. corn belt
  Google profits soar in 2nd quarter
  清涼海風:Talk of the town
  Former US congressional leaders urge reform
  Make beautiful music under the stars at Ravinia






主站蜘蛛池模板: 日韩激情中文字幕一区二区 | 日本妇人成熟免费不卡片 | 欧美中文在线观看 | 香蕉视频99 | 成人在线一区二区 | 九九99久久| 久久国内精品 | 欧美日韩高清一区 | 九九热视频免费 | 一级毛片视频 | 日本特黄特色大片免费视频 | 91伊人久久| 亚洲特一级毛片 | 国产成人视屏 | 日韩福利视频在线 | 精品国产一区二区在线 | 日本久久黄色 | 天天操网| 国产精品一区视频 | 国产精品久久久99 | 欧美高清色视频在线播放 | 国产一区二区精品在线观看 | 三级网址日本 | 日韩在线观看中文字幕 | 浮力影院草草影院 | 免费很黄很色裸乳在线观看 | 国产在线不卡午夜精品2021 | 99re在线观看 | 中文精品久久 | 欧美一区二三区 | 国产日韩中文字幕 | 性开放的欧美大片按摩 | 国产乱码精品1区2区3区 | 丁香六月激情婷婷 | 欧美成人性色区 | 亚洲五月综合网色九月色 | a在线观看欧美在线观看 | 潘金莲强完整版 | 男女啪啪片 | 精品免费在线视频 | 日韩精品福利视频一区二区三区 |